MiR-21 is overexpressed in NPM1-mutant acute myeloid leukemias

Leukemia Research

Volumn 39, Issue 2, 2015, Pages 221-228

  Riccioni, Roberta ^a   Lulli, Valentina ^a   Castelli, Germana ^a   Biffoni, Mauro ^a   Tiberio, Rosella ^c   Pelosi, Elvira ^a   Lo Coco, Francesco ^b   Testa, Ugo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Acute myeloid leukemia; Cell differentiation; Leukemia; Membrane antigens; MicroRNA

Indexed keywords

MESSENGER RNA; MICRORNA 21; NUCLEOPHOSMIN; PROGRAMMED CELL DEATH 4 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; MICRORNA; MIRN21 MICRORNA, HUMAN; NUCLEAR PROTEIN; PDCD4 PROTEIN, HUMAN; RNA; RNA BINDING PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; PDCD4 GENE; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR GENE; UPREGULATION; BIOSYNTHESIS; CLINICAL TRIAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MUTATION; PATHOLOGY;

APOPTOSIS REGULATORY PROTEINS; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICRORNAS; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS; RNA, NEOPLASM; RNA-BINDING PROTEINS;

EID: 84921374186     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2014.11.001     Document Type: Article

References (36)

1. Shih A.H., Abdeh-Wahab O., Patel J.P., Levine P.L. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer 2012, 12:599-612.
2. White B.S., Di Persio J.F. Genomic tools in acute myeloid leukemia: from the bench to the bedside. Cancer 2014, 120:1134-1144.
3. Shivarov V., Bullinger L. Expression profiling of leukemic patients: key lessons and future directions. Exp Hematol 2014, 42:651-660.
4. Hotchiss R.S., Strasser A., McDunn J., Swanson P.E. Cell death. N Engl J Med 2009, 361:1570-1583.
5. Kelly G., Strasser A. The essential role of evasion from cell death in cancer. Adv Cancer Res 2011, 111:39-96.
6. Laukat-Buttgerert B., Goke R. The tumor suppressor PDCD4: recent advances in the elucidation of function and regulation. Biol Cell 2009, 101:309-317.
7. Eto K., Goto S., Nakashima W., Uza Y., Abe S.I. Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA. Cell Death Differ 2012, 19:573-581.
8. Lu Z., Liu M., Stribinskis V., Klinge C.M., Ramos K.S., Colburn N.H., et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008, 27:4373-4379.
9. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasion and metastasis in colorectal cancer. Oncogene 2008, 27:2128-2136.
10. Fu X., Han Y., Wu Y., Zhu X., Lu X., Mao F., et al. Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis. Eur J Clin Invest 2011, 41:1245-1253.
11. Rossi S., Shimizu M., Barbarotto E., Nicoloso M.S., Dimitri F., Sampath D., et al. MicroRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood 2010, 116:945-952.
12. Volinia S., Galasso M., Costinean S., Tagliavini L., Gamberoni G., Drusco A., et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res 2010, 20:589-599.
13. Becker Buscaglia L.E., Li Y. Apoptosis and the target genes of microRNA-21. Chin J Cancer 2011, 30:371-380.
14. Garzon R., Garofalo M., Martelli M.P., Briesewitz R., Wang L., Fernandez-Cymering C., et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 2008, 105:3945-3950.
15. Jongen-Lavrencic M., Sun S.M., Dikstra M.K., Valkj P.J., Lowenberg B. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 2008, 111:5078-5085.
16. Tefferi A., Thiele J., Vardiman J.W. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer 2009, 115:3842-3847.
17. Dohner H., Estey E., Amadori S., Appelbaum F., Buchner T., Burnett A., et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel on behalf of the European Leukemia Net. Blood 2010, 115:453-474.
18. Mrozek K., Marcucci G., Nicolet D., Maharry K.S., Becker H., Whitman S.P., et al. Prognostic significance of the European Net standardization system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia. J Clin Oncol 2012, 30:4515-4523.
19. Grossmann V., Schnittger S., Kohlmann A., Eder C., Roller A., Dicker F., et al. A novel hierarchical prognostic model of AML solely based on molecular mutations. Blood 2012, 120:2963-2972.
20. + AML): biologic and clinical features. Blood 2007, 109:874-885.
21. Falini B., Martelli M.P., Bolli N., Sportoletti P., Liso A., Tiacci E., et al. Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?. Blood 2011, 117:1109-1120.
22. Schneider F., Hoster E., Unterhalt M., Schneider S., Dufour A., Benthaus T., et al. The FLT3-ITD mRNA level has a prognostic normal karyotype. Blood 2012, 119:4383-4386.
23. Gordon J., Wang J., Rosko J. MicroRNA in myeloid malignancies. Br J Haematol 2013, 162:162-176.
24. Schotte D., Pieters R., Den Boer M.L. MicroRNAs in acute leukemia: from biological players to clinical contributors. Leukemia 2012, 26:1-12.
25. Velu C.S., Baktula A.M., Grimes H.L. Gfi 1 regulates miR-21 and miR-196b to control myelopoiesis. Blood 2009, 113:4720-4728.
26. Chomczynsky P., Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction. Anal Biochem 1987, 162:156-159.
27. Noguera N.I., Ammatuna E., Zangrilli D., Lavorgna S., Divona M., Buccisano F., et al. Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia. Leukemia 2005, 19:1479-1482.
28. Lulli V., Romania P., Morsilli O., Cianciulli P., Gabbianelli M., Testa U., et al. Micro-RNA-486-3p regulates gamma-globin expression in human erythroid cells by directly modulating BCL11A. PLOS ONE 2013, 8:pe60436.
29. Testa U., Riccioni R., Militi S., Coccia E., Stellacci E., Samoggia P., et al. Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis. Blood 2002, 100:2980-2988.
30. Nomedadea J., Bussaglia E., Villemor N., Martinez C., Esteve J., Tormo M., et al. Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment size. Leuk Res 2011, 35:163-168.
31. Liu Y.R., Zhu H.H., Ruan G.R., Qin Y.Z., Shi H.X., Lai Y.Y., et al. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes. Leuk Res 2013, 37:737-741.
32. Port M., Bottcher M., Thol F., Ganser A., Schlenk R., Wsem J., et al. Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis. Ann Hematol 2014, 93:1279-1286.
33. Velu C., Chaubey A., Phelan J., Horman S., Wunderlich M., Guzman M., et al. Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity. J Clin Invest 2014, 124:222-236.
34. Yamaka Y., Tagawa H., Takahashi N., Watanabe A., Guo Y.M., Iwamoto K., et al. aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood 2009, 114:3265-3275.
35. Bai H., Xu R., Cao Z., Wei D., Wang C. Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukemic K562 cell line. FEBS Lett 2011, 585:402-408.
36. Noguera N.I., Song M.S., Divona M., Catalano G., Calvo K.L., Garcia F., et al. Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia. Leukemia 2013, 27:1037-1043.